Literature DB >> 16195260

Antimalarial treatment with artemisinin combination therapy in Africa.

Grace Malenga, Ayo Palmer, Sarah Staedke, Walter Kazadi, Theonest Mutabingwa, Evelyn Ansah, Karen I Barnes, Christopher J M Whitty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16195260      PMCID： PMC1239958          DOI： 10.1136/bmj.331.7519.706

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Improving malaria home treatment by training drug retailers in rural Kenya.

Authors:  V M Marsh; W M Mutemi; A Willetts; K Bayah; S Were; A Ross; K Marsh
Journal:  Trop Med Int Health       Date:  2004-04       Impact factor: 2.622

2.  Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial.

Authors:  Sarah G Staedke; Arthur Mpimbaza; Moses R Kamya; Bridget K Nzarubara; Grant Dorsey; Philip J Rosenthal
Journal:  Lancet       Date:  2004 Nov 27-Dec 3       Impact factor: 79.321

3.  Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.

Authors:  Dejan Zurovac; Mickey Ndhlovu; Alexander K Rowe; Davidson H Hamer; Donald M Thea; Robert W Snow
Journal:  BMJ       Date:  2005-10-01

4.  Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.

Authors:  Theonest K Mutabingwa; Devota Anthony; Archie Heller; Rachel Hallett; Jalal Ahmed; Chris Drakeley; Brian M Greenwood; Christopher J M Whitty
Journal:  Lancet       Date:  2005 Apr 23-29       Impact factor: 79.321

5.  Malaria misdiagnosis: effects on the poor and vulnerable.

Authors:  Mark Amexo; Rachel Tolhurst; Guy Barnish; Imelda Bates
Journal:  Lancet       Date:  2004 Nov 20-26       Impact factor: 79.321

6.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

7.  Artesunate combinations for treatment of malaria: meta-analysis.

Authors:  M Adjuik; A Babiker; P Garner; P Olliaro; W Taylor; N White
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

8.  Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa.

Authors:  Charlotte Muheki; Di McIntyre; Karen I Barnes
Journal:  Trop Med Int Health       Date:  2004-09       Impact factor: 2.622

9.  Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study.

Authors:  Hugh Reyburn; Redepmta Mbatia; Chris Drakeley; Ilona Carneiro; Emmanuel Mwakasungula; Ombeni Mwerinde; Kapalala Saganda; John Shao; Andrew Kitua; Raimos Olomi; Brian M Greenwood; Christopher J M Whitty
Journal:  BMJ       Date:  2004-11-12
  9 in total
  9 in total

Review 1.  Combination therapies for combating antimicrobial resistance.

Authors:  Michael A Fischbach
Journal:  Curr Opin Microbiol       Date:  2011-09-06       Impact factor: 7.934

2.  Who gets prompt access to artemisinin-based combination therapy? A prospective community-based study in children from rural Kilosa, Tanzania.

Authors:  Daudi O Simba; Marian Warsame; Deodatus Kakoko; Zakayo Mrango; Goran Tomson; Zul Premji; Max Petzold
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

3.  Artemisinin and a series of novel endoperoxide antimalarials exert early effects on digestive vacuole morphology.

Authors:  Maria del Pilar Crespo; Thomas D Avery; Eric Hanssen; Emma Fox; Tony V Robinson; Peter Valente; Dennis K Taylor; Leann Tilley
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

4.  Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests?

Authors:  Charlotte M Zikusooka; Diane McIntyre; Karen I Barnes
Journal:  Malar J       Date:  2008-09-15       Impact factor: 2.979

5.  Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.

Authors:  Hasifa Bukirwa; Adoke Yeka; Moses R Kamya; Ambrose Talisuna; Kristin Banek; Nathan Bakyaita; John Bosco Rwakimari; Philip J Rosenthal; Fred Wabwire-Mangen; Grant Dorsey; Sarah G Staedke
Journal:  PLoS Clin Trials       Date:  2006-05-19

6.  A comparative, randomized clinical trial of artemisinin/naphtoquine twice daily one day versus artemether/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire.

Authors:  Offianan A Toure; Louis K Penali; Jean-Didier Yapi; Berenger A Ako; Walamtchin Toure; Kali Djerea; Genevieve O Gomez; Oyewole Makaila
Journal:  Malar J       Date:  2009-07-03       Impact factor: 2.979

7.  Malaria in children.

Authors:  Richard-Fabian Schumacher; Elena Spinelli
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-11-06       Impact factor: 2.576

8.  Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial.

Authors:  Moses R Kamya; Adoke Yeka; Hasifa Bukirwa; Myers Lugemwa; John B Rwakimari; Sarah G Staedke; Ambrose O Talisuna; Bryan Greenhouse; François Nosten; Philip J Rosenthal; Fred Wabwire-Mangen; Grant Dorsey
Journal:  PLoS Clin Trials       Date:  2007-05-18

Review 9.  Prospects for the treatment of drug-resistant malaria parasites.

Authors:  Leann Tilley; Timothy M E Davis; Patrick G Bray
Journal:  Future Microbiol       Date:  2006-06       Impact factor: 3.165
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.